Navigation Links
Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
Date:9/4/2012

BILLERICA, Mass., Sept. 4, 2012 /PRNewswire/ -- Aushon BioSystems today announced that Martin Verhoef has been appointed Chief Executive Officer.  Mr. Verhoef has also been appointed to the Company's Board of Directors. Peter Honkanen, Founder and former Chief Executive Officer, will assume the Chief Operating Officer role and continue as a Board Director.

(Logo: http://photos.prnewswire.com/prnh/20120621/NE25431LOGO)

"We welcome Martin to Aushon and are especially excited about the extensive commercialization experience he brings to the organization.  Now that the company has achieved its product development milestones, it's sharpening its focus on the commercialization of its products.  With his background and experience, Martin offers the right leadership to realize the company's potential," commented Rich D'Amore, Founding Partner of North Bridge Venture Partners.

"I'm very excited to work with Martin and to shift my focus to further strengthening the Development and Operations teams as we prepare the organization for substantial growth," added Peter Honkanen.

Mr. Verhoef has a career of over 25 years experience in the life science research tools and molecular diagnostics business.  Prior to joining Aushon, Mr. Verhoef was Chief Executive Officer at the molecular diagnostic firms MiraDx and PrimeraDx. He was also a member of Ciphergen's executive team where he led the company's BioSystems Division. Mr. Verhoef has also held various senior management roles at Agilent in Germany and the US.  He holds BS degrees in Medical Chemistry and Chemistry from the van 't Hoff Institute in Rotterdam, The Netherlands.

"I am delighted to be joining Aushon at this stage of its development. The new Cira™ platform has been exceptionally well received and is already being adopted by key customers throughout the life science industry. I strongly believe that CiraPlex™ will become the platform of choice for protein biomarker analysis and will help drive personalized medicine," commented Mr. Verhoef.

About Aushon

Aushon BioSystems, Inc., provides a comprehensive suite of multiplex immunoassay products and services for protein biomarker discovery, development, and analysis to leading pharmaceutical, biotechnology, academic, and diagnostic clients worldwide. Our unique combination of proprietary microarray printing, extensive biomarker content, and our innovative Cira immunoassay platform deliver exceptional performance, quality, and reliability to accelerate preclinical and clinical biomarker research. Our customers, who include nine of the top ten pharmaceutical companies, trust Aushon to supply the most reliable biomarker data available, lowering costs and improving research productivity.

Aushon Contact:

Rocco Raduazo

Vice President, Sales & Marketing
1-877-AUSHON-1
E-mail: info@aushon.com


'/>"/>
SOURCE Aushon BioSystems
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
2. BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President
3. BioNeutral Group Appoints A New Member to the Board of Directors
4. Western Carolina University, College of Business Appoints New Director of Entrepreneurship and Innovation
5. JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
6. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
7. ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
8. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
9. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
10. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
11. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
Breaking Biology News(10 mins):